Dr. Robert Joseph Murray Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 171 W Lancaster Ave, Paoli, PA 19301 Phone: 610-889-0419 |
Mariana Scutaru Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 W Central Ave, Paoli, PA 19301 Phone: 267-690-0672 |
Mrs. Elaine Kopelman, M.F.T. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 171 W Lancaster Ave, Paoli, PA 19301 Phone: 610-594-9808 Fax: 610-889-1537 |
Gerald Surette, PHD Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1440 Russell Rd, Paoli, PA 19301 Phone: 610-644-6464 |
Mrs. Kerstin Miller, M.DIV, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 171 W Lancaster Ave, 2nd Floor, Paoli, PA 19301 Phone: 610-889-0419 Fax: 610-889-1537 |
H James Cline, MED Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1440 Russell Rd, Paoli, PA 19301 Phone: 610-644-6464 |
Mrs. Sue D Milbourne, MS LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 171 W Lancaster Ave, Paoli, PA 19301 Phone: 610-889-0419 |
News Archive
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled "Biomarkers of Metabolic Responses to Hepatic Drugs". The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.
HIV has been transformed into a chronic, manageable disease for most people living with HIV in the United States, where mother-to-child transmission of HIV is now a rare occurrence.
The U.S. Food and Drug Administration (FDA) today is warning consumers not to use the Triaminic Vapor Patch marketed by Novartis Consumer Health due to reports of serious adverse events associated with accidental ingestion by children.
Today's early morning highlights from the major news organizations, including reports from the administration about the number of insurers that will be offering policies on the new online marketplaces.
Coherex Medical, Inc. today announced that it has closed a $16.5 million Series B Preferred Stock financing. After the close of this investment, Coherex has now raised nearly $28.0 million in equity financing from outside funding sources since inception.
› Verified 3 days ago